Standout Papers
Citation Impact
Citing Papers
Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice
2013
Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis
2016
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Extracellular DNA traps released by acute promyelocytic leukemia cells through autophagy
2016
PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
2016
Shear stress enhances the proteolysis of von Willebrand factor in normal plasma
1994
A Review of the Technical, Diagnostic, and Epidemiologic Considerations for Protein S Assays
2002
Role of the hexapeptide disulfide loop present in the .gamma.-carboxyglutamic acid domain of human protein C in its activation properties and in the in vitro anticoagulant activity of activated protein C
1991
Mechanisms of Thrombus Formation
2008 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Biological functions of fucose in mammals
2017
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Neutrophil extracellular traps promote deep vein thrombosis in mice
2011
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
1994
Antithrombotic Therapy for VTE Disease
2016 Standout
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
The molecular basis of blood coagulation
1988 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Risk Factors of Cerebral Vein and Sinus Thrombosis
2007
Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
2018
Polyacrylamide-based glycoconjugates as tools in glycobiology
1998
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
IgG4-Related Disease
2012 Standout
Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Myocardial Infarction in Postmenopausal Women
2001
Physiological aspects of high-altitude pulmonary edema
2005
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Prevention of High-Altitude Pulmonary Edema by Nifedipine
1991
Platelets in atherothrombosis
2002
Purification of Salmon Clotting Factors and Their Use as Tissue Sealants
2000
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Coagulation Systems of Invertebrates and Vertebrates and Their Roles in Innate Immunity: The Same Side of Two Coins?
2010
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin‐dependent protein C activation
2011
Neutrophil extracellular traps in immunity and disease
2017 Standout
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Autoimmune heparin‐induced thrombocytopenia
2017
Antithrombin III (ATILL) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study
1998
Nonlinear elasticity in biological gels
2005 StandoutNature
Autoactivation of human recombinant coagulation factor VII
1989
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
High-Altitude Illness
2001 Standout
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
2009
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Cyclosporine
1989 Standout
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura
1998
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice
2008
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets
2003
Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis)
2014
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Neutrophil elastase‐deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis
2015
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Inherited prothrombotic risk factors and cerebral venous thrombosis
1998
Extracellular histones are major mediators of death in sepsis
2009 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura
2001
Purification of human von Willebrand factor–cleaving protease and its identification as a new member of the metalloproteinase family
2001
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Involutional Osteoporosis
1986 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis1
2008
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
1986
Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
2012
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Synthesis of Glycopolymers for Microarray Applications via Ligation of Reducing Sugars to a Poly(acryloyl hydrazide) Scaffold
2010 StandoutNobel
Defective thrombus formation in mice lacking coagulation factor XII
2005
THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS
1985
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Trousseau's syndrome: multiple definitions and multiple mechanisms
2007
Cerebral Venous Thrombosis After Epidural Blood Patch: Coincidence or Causal Relation? A Case Report and Review of the Literature
2008
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
2001
A Self-Assembled Multivalent Pseudopolyrotaxane for Binding Galectin-1
2004 StandoutNobel
Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis
1993
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
1996
Factor V Leiden Mutation Is a Risk Factor for Cerebral Venous Thrombosis
1998
Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo
2003
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
2011
Proteolytic Cleavage of Recombinant Type 2A von Willebrand Factor Mutants R834W and R834Q: Inhibition by Doxycycline and by Monoclonal Antibody VP-1
1997
Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy
1997
Characteristics of protein–carbohydrate interactions as a basis for developing novel carbohydrate‐based antirejection therapies
2005
Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4
2011
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome
2000
Cerebral venous thrombosis
2004
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Intrinsic Pathway of Coagulation and Arterial Thrombosis
2007
The Suprapharmacologic Dosing of Antithrombin Concentrate for Staphylococcus Aureus-Induced Disseminated Intravascular Coagulation in Guinea Pigs: Substantial Reduction in Mortality and Morbidity
1997
Venous thrombosis: a multicausal disease
1999 Standout
Peptidylarginine deiminase 4 promotes age-related organ fibrosis
2016
1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.
1982
Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
1996
Localization of ADAMTS13 to the stellate cells of human liver
2005
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of Bernhard Lämmle being referenced
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V
1993
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
IN VITRO EVALUATION OF THE EFFICACY AND BIOCOMPATIBILITY OF NEW, SYNTHETIC ABO IMMUNOABSORBENTS
1995
Factor XIII in severe sepsis and septic shock
2006
Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor‐cleaving protease
2001
Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control study
1999
Plasma DNA is elevated in patients with deep vein thrombosis
2013
Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis
1997
Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies
2014
Subcutaneous low-molecular-weight heparin for treatment of Trousseau’s syndrome
1997
The novel acceptor splice site mutation 11396(G->A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients
1995
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease
2001
ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13
2003
Elevated nucleosome levels in systemic inflammation and sepsis*
2003
C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction
2002
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis
2007
Heparin-dependent in vitro aggregation of normal platelets by plasma of a patient with heparin-induced skin necrosis: specific diagnostic test for a rare side effect
1988
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
2012
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
2003
Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
1993
[Criteria for hemostasis in kidney transplant patients. Comparison of patients undergoing immunosuppression with cyclosporin and azathioprine steroids].
1984
Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies
2012
The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency
2005
von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse models
2010
Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication
1994
Case 5: Prolonged thrombin time in a patient with multiple myeloma
1999
Immunoblotting studies of the molecular forms of protein C in plasma
1988
Coagulation Factors II, V, VII, and X, Prothrombin Gene 20210G→A Transition, and Factor V Leiden in Coronary Artery Disease
1999
1,25 (OH)2Vitamin D3in Osteoporosis - A Pilot Study
1979
Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII Deficiency
1999
Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWF
1999
Factor VIII (Procoagulant Activity VIII:C, and Antigen VIII:CAg, Related Antigen VIIIR:Ag and Ristocetin Cofactor VIIIR:Cof) in Intensive Care Patients with Clinically Suspected Disseminated Intravascular Coagulation (DIC)
1984
Plasma Prekallikrein, Factor XII, Antithrombin III, C1−-Inhibitor and α2-Macroglobulin in Critically III Patients with Suspected Disseminated Intravascular Coagulation (DIC)
1984
Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.
1999
Autoactivation of human plasma prekallikrein.
1987
Thromboembolism and Bleeding Tendency in Congenital Factor XII DeficienCy - A Study on 74 Subjects from 14 Swiss Families
1991
Quantitative immunoblotting assay of blood coagulation factor XII
1986
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1997
Contact phase of blood coagulation is not activated in edema of high altitude
1989
Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)
2002
Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura
1999
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
2001